UBS Group’s Citius Pharmaceuticals, Inc. Warrant CTXRW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-117
| Closed | – | – | 10489 |
|
|
2022
Q2 | $0 | Sell |
117
-86
| -42% | – | ﹤0.01% | 10354 |
|
|
2022
Q1 | $0 | Buy |
203
+107
| +111% | – | ﹤0.01% | 10119 |
|
|
2021
Q4 | $0 | Buy |
+96
| New | – | ﹤0.01% | 9828 |
|
|
2021
Q2 | – | Sell |
-30
| Closed | – | – | 8899 |
|
|
2021
Q1 | $0 | Buy |
+30
| New | – | ﹤0.01% | 8462 |
|
|
2020
Q2 | – | Sell |
-3,826
| Closed | -$1K | – | 7458 |
|
|
2020
Q1 | $1K | Sell |
3,826
-2,375
| -38% | -$621 | ﹤0.01% | 6930 |
|
|
2019
Q4 | $1K | Buy |
6,201
+26
| +0.4% | +$4 | ﹤0.01% | 6939 |
|
|
2019
Q3 | $1K | Hold |
6,175
| – | – | ﹤0.01% | 6914 |
|
|
2019
Q2 | $1K | Buy |
6,175
+5,400
| +697% | +$874 | ﹤0.01% | 6885 |
|
|
2019
Q1 | $0 | Sell |
775
-325
| -30% | – | ﹤0.01% | 7258 |
|
|
2018
Q4 | $0 | Buy |
1,100
+100
| +10% | – | ﹤0.01% | 7319 |
|
|
2018
Q3 | $0 | Buy |
+1,000
| New | – | ﹤0.01% | 7264 |
|
|
2018
Q1 | – | Sell |
-4,265
| Closed | -$2K | – | 7155 |
|
|
2017
Q4 | $2K | Buy |
4,265
+1,100
| +35% | +$516 | ﹤0.01% | 6669 |
|
|
2017
Q3 | $2K | Buy |
+3,165
| New | +$2K | ﹤0.01% | 6580 |
|